Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Financial Flexibility Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥131.84 Million (operating CF CN¥110.78 Million minus capex CN¥21.06 Million) represents 0% of total liabilities (CN¥2.56 Billion). Also explore net asset momentum of Tianjin Zhongxin Pharmaceutical Group Co to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. Check 600329 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full company profile including market capitalisation, see 600329 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥1.04 Billion | CN¥924.67 Million | CN¥2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | CN¥829.42 Million | CN¥688.49 Million | CN¥3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | CN¥785.15 Million | CN¥677.25 Million | CN¥3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | CN¥1.01 Billion | CN¥852.40 Million | CN¥2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | CN¥860.58 Million | CN¥671.42 Million | CN¥2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | CN¥701.10 Million | CN¥495.49 Million | CN¥2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | CN¥525.95 Million | CN¥350.14 Million | CN¥2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | CN¥110.45 Million | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -78.8% |
| 2016 | 0.26x | CN¥536.10 Million | CN¥419.90 Million | CN¥2.06 Billion | ▲ +12.8% |
| 2015 | 0.23x | CN¥453.22 Million | CN¥360.58 Million | CN¥1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | CN¥357.01 Million | CN¥286.85 Million | CN¥2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | CN¥285.86 Million | CN¥213.44 Million | CN¥2.69 Billion | ▲ +267.5% |
| 2012 | 0.03x | CN¥61.98 Million | CN¥20.81 Million | CN¥2.14 Billion | ▼ -74.1% |
| 2011 | 0.11x | CN¥216.90 Million | CN¥173.88 Million | CN¥1.94 Billion | ▼ -5.8% |
| 2010 | 0.12x | CN¥207.82 Million | CN¥139.04 Million | CN¥1.75 Billion | ▲ +31.2% |
| 2009 | 0.09x | CN¥170.15 Million | CN¥83.41 Million | CN¥1.88 Billion | ▼ -8.0% |
| 2008 | 0.10x | CN¥194.13 Million | CN¥155.77 Million | CN¥1.97 Billion | ▲ +183.4% |
| 2007 | 0.03x | CN¥73.87 Million | CN¥20.13 Million | CN¥2.13 Billion | ▲ +104.4% |
| 2006 | 0.02x | CN¥35.66 Million | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -91.3% |
| 2005 | 0.20x | CN¥411.70 Million | CN¥261.91 Million | CN¥2.11 Billion | ▲ +51.4% |
| 2004 | 0.13x | CN¥262.80 Million | CN¥10.50 Million | CN¥2.04 Billion | ▼ -62.0% |
| 2003 | 0.34x | CN¥665.77 Million | CN¥76.57 Million | CN¥1.96 Billion | ▲ +21.8% |
| 2002 | 0.28x | CN¥368.00 Million | CN¥187.60 Million | CN¥1.32 Billion | ▲ +12.7% |
| 2001 | 0.25x | CN¥291.68 Million | CN¥157.73 Million | CN¥1.18 Billion | — |